Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wiesli

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Praxis|March 5, 2026
[Modern treatment of type 2 diabetes: 3 medications and 3 targets]Peter Wiesli
Circulation|December 18, 2002
Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive diseasePeter Wiesli, Georg Schulthess
Praxis|April 12, 2023
[GLP-1 Receptor Agonists: For Which Patients with Type-2 Diabetes?]Tobias Mächler, Peter Wiesli
Praxis|September 3, 2020
[CME Answers: Primary and Secondary Hypercholesterolemia]Susanna Hofbauer, Peter Wiesli
The New England Journal of Medicine|January 14, 2011
Images in clinical medicine. Auricular cartilage calcification and adrenal insufficiencyHeiko Uthoff, Peter Wiesli
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 11, 2018
Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo<sup>®</sup>) in Patients with Type 2 Diabetes: Real-World Effectiveness in SwitzerlandPeter Wiesli, Marcus Schories
Praxis|August 6, 2020
[CME: Primary and Secondary Hypercholesterolemia]Susanna Hofbauer, Peter Wiesli
Praxis|August 17, 2022
[CME: Can Slim People Have Type-2 Diabetes?]Simona Danioth, Peter Wiesli
International Journal of Cardiology|November 1, 2005
Chlamydia pneumoniae, harmful only for peripheral arteries?Georg Schulthess, Peter Wiesli, Pierre Krayenbuehl
Clinical Chemistry|August 27, 2002
Macrolide treatment does not influence serum homocysteine in Chlamydia pneumoniae-seropositive patients suffering from atherosclerosisGeorg Schulthess, Peter Wiesli, Friedrich E Maly
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Praxis|March 5, 2026
[Modern treatment of type 2 diabetes: 3 medications and 3 targets]Peter Wiesli
Circulation|December 18, 2002
Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive diseasePeter Wiesli, Georg Schulthess
Praxis|April 12, 2023
[GLP-1 Receptor Agonists: For Which Patients with Type-2 Diabetes?]Tobias Mächler, Peter Wiesli
Praxis|September 3, 2020
[CME Answers: Primary and Secondary Hypercholesterolemia]Susanna Hofbauer, Peter Wiesli
The New England Journal of Medicine|January 14, 2011
Images in clinical medicine. Auricular cartilage calcification and adrenal insufficiencyHeiko Uthoff, Peter Wiesli
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 11, 2018
Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo<sup>®</sup>) in Patients with Type 2 Diabetes: Real-World Effectiveness in SwitzerlandPeter Wiesli, Marcus Schories
Praxis|August 6, 2020
[CME: Primary and Secondary Hypercholesterolemia]Susanna Hofbauer, Peter Wiesli
Praxis|August 17, 2022
[CME: Can Slim People Have Type-2 Diabetes?]Simona Danioth, Peter Wiesli
International Journal of Cardiology|November 1, 2005
Chlamydia pneumoniae, harmful only for peripheral arteries?Georg Schulthess, Peter Wiesli, Pierre Krayenbuehl
Clinical Chemistry|August 27, 2002
Macrolide treatment does not influence serum homocysteine in Chlamydia pneumoniae-seropositive patients suffering from atherosclerosisGeorg Schulthess, Peter Wiesli, Friedrich E Maly
Pageof 6